The EBNA2-related resistance towards alpha interferon (IFN-alpha) in Burkitt's lymphoma cells effects induction of IFN-induced genes but not the activation of transcription factor ISGF-3
- PMID: 1406670
- PMCID: PMC360425
- DOI: 10.1128/mcb.12.11.4930-4936.1992
The EBNA2-related resistance towards alpha interferon (IFN-alpha) in Burkitt's lymphoma cells effects induction of IFN-induced genes but not the activation of transcription factor ISGF-3
Erratum in
- Mol Cell Biol 1993 Mar;13(3):1981
Abstract
Transfection of a plasmid encoding the Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA2) gene confers resistance to the antiproliferative effect of alpha interferon (IFN-alpha) in EBV-negative U968 cells (P. Aman and A. von Gabain, EMBO J. 9:147-152, 1990). We studied the expression of IFN-stimulated genes (ISGs) in two pairs of Burkitt's lymphoma cell lines, differing in the expression of the putative immortalizing gene of EBV, EBNA2. In EBNA2-expressing cells, the induction of four ISGs by IFN-alpha was strongly reduced or, in some cases, abolished. Chloramphenicol acetyltransferase reporter gene constructs containing different IFN-stimulated response elements were transfected into EBNA2-negative and EBNA2-positive cells. Induction of chloramphenicol acetyltransferase activity by IFN was impaired in EBNA2-positive cells. Also, a reporter gene construct driven by an IFN-gamma-sensitive promoter element was affected. However, as revealed by gel shift assays, EBNA2-positive and EBNA2-negative cells exhibited a nearly identical pattern of IFN-stimulated response element-binding proteins. Most important, activation of the factor ISGF-3, which previously has been shown to be required and sufficient for transcriptional activation of IFN-induced genes, was not inhibited in IFN-resistant cells expressing EBNA2. The mechanism of the EBNA2-related IFN resistance seems to be distinct both from the resistance mediated by hepatitis virus and adenovirus gene products and from the IFN resistance in Daudi cell variants. In these three cases, the transcriptional block of IFN-induced genes is due to inhibition of ISGF-3 activation and binding. Our data suggest that the EBNA2-related IFN resistance in Burkitt's lymphoma cells acts downstream of the activation of ISGF-3.
Similar articles
-
The Epstein-Barr virus nuclear antigen 2 (EBNA2), a protein required for B lymphocyte immortalization, induces the synthesis of type I interferon in Burkitt's lymphoma cell lines.Biol Chem. 1999 Feb;380(2):213-21. doi: 10.1515/BC.1999.029. Biol Chem. 1999. PMID: 10195428
-
Both Epstein-Barr viral nuclear antigen 2 (EBNA2) and activated Notch1 transactivate genes by interacting with the cellular protein RBP-J kappa.Immunobiology. 1997 Dec;198(1-3):299-306. doi: 10.1016/s0171-2985(97)80050-2. Immunobiology. 1997. PMID: 9442401 Review.
-
Epstein-Barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin mu gene: implications for the expression of the translocated c-myc gene in Burkitt's lymphoma cells.EMBO J. 1996 Jan 15;15(2):375-82. EMBO J. 1996. PMID: 8617212 Free PMC article.
-
Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.J Virol. 1993 May;67(5):2853-61. doi: 10.1128/JVI.67.5.2853-2861.1993. J Virol. 1993. PMID: 8386279 Free PMC article.
-
Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene.J Virol. 1991 Jan;65(1):415-23. doi: 10.1128/JVI.65.1.415-423.1991. J Virol. 1991. PMID: 1845900 Free PMC article.
Cited by
-
Strategies of Epstein-Barr virus to evade innate antiviral immunity of its human host.Front Microbiol. 2022 Jul 22;13:955603. doi: 10.3389/fmicb.2022.955603. eCollection 2022. Front Microbiol. 2022. PMID: 35935191 Free PMC article. Review.
-
Epstein-Barr Virus-Associated Malignancies and Immune Escape: The Role of the Tumor Microenvironment and Tumor Cell Evasion Strategies.Cancers (Basel). 2021 Oct 16;13(20):5189. doi: 10.3390/cancers13205189. Cancers (Basel). 2021. PMID: 34680337 Free PMC article. Review.
-
A STING inhibitor suppresses EBV-induced B cell transformation and lymphomagenesis.Cancer Sci. 2021 Dec;112(12):5088-5099. doi: 10.1111/cas.15152. Epub 2021 Oct 11. Cancer Sci. 2021. PMID: 34609775 Free PMC article.
-
Epstein-Barr Virus Early Protein BFRF1 Suppresses IFN-β Activity by Inhibiting the Activation of IRF3.Front Immunol. 2020 Dec 17;11:513383. doi: 10.3389/fimmu.2020.513383. eCollection 2020. Front Immunol. 2020. PMID: 33391252 Free PMC article.
-
Epstein-Barr Virus (EBV) Tegument Protein BGLF2 Suppresses Type I Interferon Signaling To Promote EBV Reactivation.J Virol. 2020 May 18;94(11):e00258-20. doi: 10.1128/JVI.00258-20. Print 2020 May 18. J Virol. 2020. PMID: 32213613 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials